If you have diabetes, your doctor may prescribe Tresiba. Tresiba is a prescription drug that’s used to manage blood sugar levels. Tresiba is used in adults and some children to treat type 1 or type 2 ...
Tresiba (insulin degludec) and Lantus (insulin glargine) are brand-name prescription medications. They’re approved by the Food and Drug Administration (FDA) to treat type 1 and type 2 diabetes in ...
Tresiba and Lantus are both long-acting insulins used to manage blood sugar levels in people with type 1 or type 2 diabetes. (For more information on each’s drug uses, see the “What are Tresiba and ...
Dosage for Tresiba (insulin degludec) depends on the type of diabetes (type 1 or type 2) it is prescribed for and other factors. Your doctor may adjust your dosage over the course of your treatment.
PLAINSBORO, N.J., Sept. 25, 2015 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for ...
Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) adopted positive opinions, recommending marketing authorisations, ...
PLAINSBORO, N.J., Jan. 26, 2016 /PRNewswire/ -- Novo Nordisk, a world leader in diabetes care, today announced the availability of its newest insulin, Tresiba® (insulin degludec injection), a ...
People with diabetes have been hit with a five-month shortage of a vital medication. The Tresiba FlexTouch U100 insulin pen, which is manufactured by global pharmaceutical giant Novo Nordisk, is ...
Novo Nordisk has received European approval for two new diabetes products – Tresiba and Ryzodeg – that are central to its growth plans for the next few years. Tresiba (insulin degludec) and Ryzodeg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback